If you're interested in becoming a contributor or requesting changes then click here to join the discord
Difference between revisions of "Axonics Modulation Technologies"
Jump to navigation
Jump to search
Landonodnal (talk | contribs) |
Landonodnal (talk | contribs) |
||
| Line 1: | Line 1: | ||
| + | [[Category:LinkedIn Accounts]] | ||
| + | [[Category:YouTube Channels]] | ||
| + | [[Category:Instagram Pages]] | ||
| + | [[Category:Facebook Pages]] | ||
[[Category:Organizations]] | [[Category:Organizations]] | ||
[[Category:Companies]] | [[Category:Companies]] | ||
| Line 17: | Line 21: | ||
[https://www.linkedin.com/company/axonics/ LinkedIn] | [https://www.linkedin.com/company/axonics/ LinkedIn] | ||
[https://facebook.com/axonics/ Facebook][https://instagram.com/axonics/ Instagram] | [https://facebook.com/axonics/ Facebook][https://instagram.com/axonics/ Instagram] | ||
| + | [https://youtube.com/channel/UCY3ELFd93I2Q47ijxIRioeg YouTube] | ||
Revision as of 06:20, 22 March 2022
Axonics is a pre-revenue company developing novel implantable neuromodulation technology licensed from The Alfred Mann Foundation directed toward a number of clinical indications, including the treatment of chronic pain and overactive bladder.
Founded in The United States around 2012, Axonics Modulation Technologies produces invasive hardware.
Axonics Modulation Technologies makes tools for medical diagnosis and treatment through body/mind state interpretation and/or neurostimulation therapies.
BCI Categories: Open-Loop Afferent
Neurostimulation Technique(s): PNS